Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes.
Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picks
Written by
in
Appointments and Executive Changes, Centers for Disease Control and Prevention, Centers for Medicare and Medicaid Services, Coronavirus (2019-nCoV), Dietary Supplements and Herbal Remedies, Drugs (Pharmaceuticals), Food and Drug Administration, Health and Human Services Department, Health Insurance and Managed Care, Kennedy, Robert F Jr, Lobbying and Lobbyists, Makary, Marty, Medicaid, Medicare, Medicine and Health, Merck & Company Inc, Moderna Inc, Nesheiwat, Janette, Oz, Mehmet C, Pfizer Inc, Politics and Government, Presidential Election of 2024, Presidential Transition (US), Prices (Fares, Fees and Rates), Regulation and Deregulation of Industry, Republican Party, Stocks and Bonds, United States Politics and Government, Vaccination and Immunization